Margenza 250 mg/10 mL (25 mg/mL) injection Images
Generic Name: margetuximab
This medication has been identified as Margenza 250 mg/10 mL (25 mg/mL) injection and is used for Breast Cancer, Metastatic. It belongs to the drug class HER2 inhibitors and is not a controlled substance.
Images of medication
Margenza
- Generic Name
- margetuximab
- Strength
- 250 mg/10 mL (25 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- HER2 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- MacroGenics, Inc.
- National Drug Code (NDC)
- 74527-0022
See also:
More about Margenza (margetuximab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.